
    
      Investigation of the effect of Grazax (ALK produced grass tablet) on asthma prevention in
      children with grass pollen allergy.

      Children in the age of 6-12 years will be randomised to either placebo or Grazax treatment.
      Grazax has been approved for treatment of grass pollen allergy in adults and children,
      diagnosed with a positive skin prick test and/or specific immunoglobulin (IgE) test to grass
      pollen and with clinically relevant symptoms. This study will explore prevention of asthma in
      children with grass pollen induced allergy.
    
  